These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29725502)

  • 1. Ciclopirox activates ATR-Chk1 signaling pathway leading to Cdc25A protein degradation.
    Shen T; Zhou H; Shang C; Luo Y; Wu Y; Huang S
    Genes Cancer; 2018 Jan; 9(1-2):39-52. PubMed ID: 29725502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciclopirox inhibits cancer cell proliferation by suppression of Cdc25A.
    Shen T; Shang C; Zhou H; Luo Y; Barzegar M; Odaka Y; Wu Y; Huang S
    Genes Cancer; 2017 Mar; 8(3-4):505-516. PubMed ID: 28680535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual regulation of Cdc25A by Chk1 and p53-ATF3 in DNA replication checkpoint control.
    Demidova AR; Aau MY; Zhuang L; Yu Q
    J Biol Chem; 2009 Feb; 284(7):4132-9. PubMed ID: 19060337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.
    Sørensen CS; Syljuåsen RG; Lukas J; Bartek J
    Cell Cycle; 2004 Jul; 3(7):941-5. PubMed ID: 15190204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small molecule 2,3-DCPE induces S phase arrest by activating the ATM/ATR-Chk1-Cdc25A signaling pathway in DLD-1 colon cancer cells.
    Bai B; Shan L; Wang J; Hu J; Zheng W; Lv Y; Chen K; Xu D; Zhu H
    Oncol Lett; 2020 Dec; 20(6):294. PubMed ID: 33101488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential roles for checkpoint kinases in DNA damage-dependent degradation of the Cdc25A protein phosphatase.
    Jin J; Ang XL; Ye X; Livingstone M; Harper JW
    J Biol Chem; 2008 Jul; 283(28):19322-8. PubMed ID: 18480045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation.
    Gatei M; Sloper K; Sorensen C; Syljuäsen R; Falck J; Hobson K; Savage K; Lukas J; Zhou BB; Bartek J; Khanna KK
    J Biol Chem; 2003 Apr; 278(17):14806-11. PubMed ID: 12588868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase.
    Jin J; Shirogane T; Xu L; Nalepa G; Qin J; Elledge SJ; Harper JW
    Genes Dev; 2003 Dec; 17(24):3062-74. PubMed ID: 14681206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bifunctional DNA alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway.
    Cui B; Johnson SP; Bullock N; Ali-Osman F; Bigner DD; Friedman HS
    Mol Pharmacol; 2009 Jun; 75(6):1356-63. PubMed ID: 19261750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents.
    Xiao Z; Chen Z; Gunasekera AH; Sowin TJ; Rosenberg SH; Fesik S; Zhang H
    J Biol Chem; 2003 Jun; 278(24):21767-73. PubMed ID: 12676925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.
    Helt CE; Cliby WA; Keng PC; Bambara RA; O'Reilly MA
    J Biol Chem; 2005 Jan; 280(2):1186-92. PubMed ID: 15533933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reposition of the Fungicide Ciclopirox for Cancer Treatment.
    Huang Z; Huang S
    Recent Pat Anticancer Drug Discov; 2021; 16(2):122-135. PubMed ID: 33573561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol causes Cdc2-tyr15 phosphorylation via ATM/ATR-Chk1/2-Cdc25C pathway as a central mechanism for S phase arrest in human ovarian carcinoma Ovcar-3 cells.
    Tyagi A; Singh RP; Agarwal C; Siriwardana S; Sclafani RA; Agarwal R
    Carcinogenesis; 2005 Nov; 26(11):1978-87. PubMed ID: 15975956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural anticancer compound rocaglamide selectively inhibits the G1-S-phase transition in cancer cells through the ATM/ATR-mediated Chk1/2 cell cycle checkpoints.
    Neumann J; Boerries M; Köhler R; Giaisi M; Krammer PH; Busch H; Li-Weber M
    Int J Cancer; 2014 Apr; 134(8):1991-2002. PubMed ID: 24150948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ATR and Chk1 suppress a caspase-3-dependent apoptotic response following DNA replication stress.
    Myers K; Gagou ME; Zuazua-Villar P; Rodriguez R; Meuth M
    PLoS Genet; 2009 Jan; 5(1):e1000324. PubMed ID: 19119425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrasound activates ataxia telangiectasia mutated- and rad3-related (ATR)-checkpoint kinase 1 (Chk1) pathway in human leukemia Jurkat cells.
    Furusawa Y; Iizumi T; Fujiwara Y; Hassan MA; Tabuchi Y; Nomura T; Kondo T
    Ultrason Sonochem; 2012 Nov; 19(6):1246-51. PubMed ID: 22571845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ciclopirox induces autophagy through reactive oxygen species-mediated activation of JNK signaling pathway.
    Zhou H; Shen T; Shang C; Luo Y; Liu L; Yan J; Li Y; Huang S
    Oncotarget; 2014 Oct; 5(20):10140-50. PubMed ID: 25294812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciclopirox olamine inhibits mTORC1 signaling by activation of AMPK.
    Zhou H; Shang C; Wang M; Shen T; Kong L; Yu C; Ye Z; Luo Y; Liu L; Li Y; Huang S
    Biochem Pharmacol; 2016 Sep; 116():39-50. PubMed ID: 27396756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapy.
    Massey AJ
    Cancer Lett; 2016 Dec; 383(1):41-52. PubMed ID: 27693461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cdk inhibition in human cells compromises chk1 function and activates a DNA damage response.
    Maude SL; Enders GH
    Cancer Res; 2005 Feb; 65(3):780-6. PubMed ID: 15705874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.